Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2025-12-31 @ 1:20 AM
Study NCT ID:
NCT00378833
Status:
COMPLETED
Last Update Posted:
2017-02-16
First Post:
2006-09-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-07
Start Date Type:
None
Primary Completion Date:
2007-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-20
First Submit QC Date:
None
Study First Post Date:
2006-09-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-15
Last Update Post Date:
2017-02-16
Last Update Post Date Type:
ACTUAL